Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 9.7B | 9.9B | 9.5B |
Cost of revenue | 3.0B | 3.4B | 3.4B | 3.3B |
Gross profit | 6.3B | 6.3B | 6.5B | 6.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.7B | 3.0B | 2.9B | 2.7B |
Other operating expenses | — | — | — | — |
Operating income | 3.5B | 3.3B | 3.7B | 3.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 241M | 946M | 189M | 329M |
Other income expense | -12M | -16M | -15M | -14M |
Pretax income | 3.3B | 2.9B | 3.5B | 3.1B |
Tax provision | 659M | 872M | 735M | 734M |
Net income | 2.8B | -486M | 3.2B | 2.5B |
Basic EPS | 1.7 | -0.4 | 2.0 | 1.5 |
Diluted EPS | 1.7 | -0.4 | 2.0 | 1.5 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 4.0B | 4.3B | 4.1B | 3.9B |
Net income from continuing op. | 2.8B | -486M | 3.2B | 2.5B |
Minority interests | -147M | -93M | -133M | -122M |
Preferred stock dividends | 8M | 1M | 9M | 7M |